FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Nanjing University School of Medicine
Nanjing University School of Medicine
University of Tennessee Graduate School of Medicine
Barbara Ann Karmanos Cancer Institute
Tufts Medical Center
Alliance for Clinical Trials in Oncology
Indiana University
University of Tennessee
University of Tennessee
Memorial Sloan Kettering Cancer Center
University of Tennessee
Northwestern University
Northwestern University
Mayo Clinic
NYU Langone Health
University of Arizona
Rutgers, The State University of New Jersey